28 news items
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
BMY
26 Apr 24
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
BMY
25 Apr 24
Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission
Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society
BMY
6 Apr 24
Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio's Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy
BMY
TSVT
5 Apr 24
Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail
European Commission Expands Approval of Bristol Myers Squibb's Reblozyl® (luspatercept) to Include First-Line Treatment of Transfusion-Dependent Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (LR-MDS)
BMY
2 Apr 24
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop
d8cx1esael3zah2ah ns334g9qy5uiype5e0
BMY
2 Apr 24
its ESG efforts. The company's ESG strategy is embedded in its mission to discover, develop, and deliver innovative medicines that help patients
2f2tmk2tfdwj7tcn4kz4pj7ehyoh00ec 17c78
BMY
25 Mar 24
Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over
omu6vz7e5rrg4a1wolvjjnzi9gm20r4de 8u612wiru9oudchk4
BMY
20 Mar 24
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative
kxh32nn0of3alxiykb0lxcfvso73wxjiupennk
BMY
TSVT
15 Mar 24
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients
w549g50breqcnms314ch23ye61etdjc1qtn
BMY
14 Mar 24
Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over
eld9q5p4kenztrwm9mxu1j8cotvb5sjqy7
BMY
7 Mar 24
biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more
a0k5b9vaeu0qrp y0v
BMY
1 Mar 24
Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail
xd4mfd2vqvj321fl0bhqphbw9ut44igyp5n
BMY
29 Feb 24
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients
exjmjofcknxdj7m73y3tupyqnafnoj4z0e eaj6wsjtntufgoep
BMY
SYY
TPR
29 Feb 24
of Bristol Myers Squibb (BMS), a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients